Publisher: Knopf, 2018, 339 pages
Bad Blood is the full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prizewinning journalist who first broke the story and pursued it to the end, despite pressure from Theranos's charismatic CEO and threats by her lawyers.
In 2015, Theranos founder and CEO Elizaeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by big-player investors, Theranos sold shares in a fund-raising round that valued the company at more than $9 billion, puttingh Holmes's worth at an estimated $4.5 billion. There was just one problem: the technology didn't work.
This is a gripping story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises and gold-rush frenzy of Silicon Valley.
A very good and in-depth description of the rise and fall of Theranos.
The only thing that stops this from getting a higher rating, is that the author fails to get under skin of the management team members, except to make them feel extremely odd (but no real explanation on why).